BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹111 Cr | ₹56 Cr | ₹52 Cr | ₹28 Cr | ₹77 Cr |
What is the latest Sundry Debtors ratio of BALAXI PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹28 Cr |
| Mar2021 | ₹77 Cr |
How is Sundry Debtors of BALAXI PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 98.90 | |
| Mar2024 | ₹56 Cr | 6.55 | |
| Mar2023 | ₹52 Cr | 89.71 | |
| Mar2022 | ₹28 Cr | -64.10 | |
| Mar2021 | ₹77 Cr | - | |
Compare Sundry Debtors of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹131.3 Cr | -5.4% | -15.9% | -63.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹284,610.0 Cr | -0.1% | -11.7% | -12.4% | Stock Analytics | |
| REDINGTON | ₹21,002.4 Cr | 3.5% | -2.2% | 31% | Stock Analytics | |
| MMTC | ₹9,414.0 Cr | -7.2% | -4.5% | -2.7% | Stock Analytics | |
| HONASA CONSUMER | ₹8,954.2 Cr | 2.7% | -3% | 23.4% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,782.3 Cr | -1.9% | -8.2% | 12.6% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -5.4% |
-15.9% |
-63.8% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses